China has put in place a series of policies to support private companies to engage in biotechnology research. This study uses data from a survey of 103 major agribusiness firms in the agricultural chemical and seed industries in China to evaluate the impact of government policies on private R&D investment in biotechnology. The results show that firms with positive profit expectation, public R&D subsidies, R&D collaboration with universities/research institutes or state-owned enterprises are more likely to embark on biotechnology research activities.
El establecimiento de prioridades de investigación e innovación es una preocupación permanente en la gobernanza de la ciencia y la tecnología, debido a que permea la definición de los objetos de estudio, la asignación de recursos por parte del Estado y la apropiación social de los resultados. Este artículo analiza las Agendas Estatales de Innovación en México, un programa impulsado por el gobierno mexicano para definir prioridades de innovación en la escala estatal.
The lessons and recommendations outlined in this paper were captured at a PAEPARD Capitalization Workshop with all partners, held in Cotonou, Benin, on 2-6 October 2017. The workshop was key to the overall evaluation of PAEPARD II, as it encouraged participants to analyse and reflect on their experiences of the AfricanEuropean MSP for ARD processes facilitated by PAEPARD over the last 7 years.
Wthin the context of ARD, capacity strengthening is seen as a process of continual development, as opposed to one-off training. It enhances interaction, builds trust and creates synergy between research institutions and public and private sector actors, smallholder farmers and development organizations. Strengthening the capacities of these different actors for collaboration enables them to address a whole range of activities, investments and policies, and take advantage of opportunities to make change happen.
The paper takes a critical look at two key interventions identified to deliver the PAEPARD capacity strengthening strategy. Firstly, the training of a pool of agricultural innovation facilitators (AIF) to broker relations between relevant stakeholders for the consolidation of effective consortia. PAEPARD envisaged the role of AIF as to support both the face-to-face and virtual (via skype, email or social media) engagement of partners in capacity strengthening processes.
This brief illustrates the different forms of knowledge, and the ways to create and manage it.
This Economic and Sector Work paper, “Enhancing Agricultural Innovation: How to Go Beyond the Strengthening of Research Systems,” was initiated as a result of the international workshop, “Development of Research Systems to Support the Changing Agricultural Sector,” organized by the Agriculture and Rural Development Department of the World Bank in June 2004 in Washington, DC.
This book documents a unique series of 19 case studies where agricultural biotechnologies were used to serve the needs of smallholders in developing countries. They cover different regions, production systems, species and underlying socio-economic conditions in the crop (seven case studies), livestock (seven) and aquaculture/fisheries (five) sectors. Most of the case studies involve a single crop, livestock or fish species and a single biotechnology.
African agriculture is currently at a crossroads, at which persistent food shortages are compounded by threats from climate change. But, as this book argues, Africa can feed itself in a generation and help contribute to global food security. To achieve this Africa has to define agriculture as a force in economic growth by: advancing scientific and technological research; investing in infrastructure; fostering higher technical training; and creating regional markets.
This PROLINNOVA report to the 3rd GFAR Programme-Committee meeting is composed of two parts.
The past 1 entitles ‘ PROLINNOVA genesis and growth’ describes historical background and
PROLINOVA in general while the part 2 entitles ‘2007 accomplishments’ narrates specific
accomplishments of PROLINNOVA during the period January-November 2007 . Further, the annex 1
lists contact addresses.